ClinicalTrials.Veeva

Menu

Depression in Adolescents. A Cerebral Structural, Diffusion, and Functional Magnetic Resonance Imaging Study (ADODEP)

C

Centre Hospitalier St Anne

Status

Unknown

Conditions

Adolescent Depression

Treatments

Other: -Diagnostic, clinical and psycho-behavioral assessments -Neuroimaging: T1-MRI, DTI-MRI, fMRI

Study type

Interventional

Funder types

Other

Identifiers

NCT01857518
D500 (Other Identifier)
2012-A01466-37

Details and patient eligibility

About

Adolescence is a critical period for the development of depressive disorders. As adolescence also is a critical period for brain maturation, it may be hypothesized that maturation changes in emotional circuits could underlie vulnerability for depression.

The aims of the study are (1) to identify the changes in brain morphometry, white matter microstructure, and functioning, in networks associated with depression features in adolescents, and (2) to assess the effects of treated pathology on brain structure by comparing the neuroimaging measures obtained in adolescents at inclusion with those at follow-up.

Full description

Adolescence is a key development period for neurobiological processes underlying emotional and cognitive functions in adulthood. The pathophysiology of mood disorders has recently been associated with maturation changes in brain networks, but little is known on the early brain structure changes associated with depression appearing during this major brain maturation period.

The hypothesis of altered structural integrity of limbic prefrontal pathways emerges from the literature on depression, but it is unknown whether it is also detectable in adolescents with depression. Thus, we aim to investigate WM and GM structure and anatomy, and functional correlates of behavioral responses in depressed adolescents.

40 adolescents with a Major Depressive Episode will be investigated using structural T1 magnetic-resonance imaging and diffusion tensor imaging (DTI), at inclusion and after one-year follow-up. Additionally, they will be investigated with fMRI.

Covariation patterns between neuroimaging and behavioural/clinical variables will be assessed.

Enrollment

80 estimated patients

Sex

All

Ages

15 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Depressed adolescents:

Teenagers of both sexes, from 15 to 18 years old, without contreindications in magnetic fields

  • affiliation to a Social insurance
  • Informed consent signed by the holders of the parental rights (a specific information note to the teenager)
  • Diagnosis DSM-IV-TR ( 2000 ) of depressive Disorder of the humor without psychotic characteristics. The symptoms will have to be persistent for 3 weeks, in spite of a coverage of support ( 2 consultations).

Exclusion criteria

  • Ferromagnetical Material in the body
  • Claustrophobia, Syndrom of post-traumatic stress, Obsessive-compulsive Disorder, Disturb Tricks, Disturbs abuse of substances
  • Intrusive disorder of the development, Disturbs hyperactivity deficit of the attention, Disorders of the conducts, Schizophrenia
  • Current antidepressant or antipsychotic psychotropic Treatment for more than 15 days in effective doses
  • Current somatic pathology, or pregnancy (urinary test of pregnancy in case of doubt)
  • Histories of cranial trauma or neurological pathology, or of lower born weight in 800g
  • History of electroconvulsivotherapy in the previous 6 months
  • Refusal to give his(her) consent or to be revised on one year after inclusion

Healthy adolescents: will be screened to be matched to the patients according to age and sex. They will have no psychiatric diagnosis, and no family history of psychiatric conditions.

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

80 participants in 2 patient groups

Depressed adolescents Group
Other group
Description:
Adolescents with a major depressive episode diagnosis
Treatment:
Other: -Diagnostic, clinical and psycho-behavioral assessments -Neuroimaging: T1-MRI, DTI-MRI, fMRI
Healthy adolescent control Group
Other group
Description:
Healthy adolescents recruited from general population
Treatment:
Other: -Diagnostic, clinical and psycho-behavioral assessments -Neuroimaging: T1-MRI, DTI-MRI, fMRI

Trial contacts and locations

1

Loading...

Central trial contact

Marie GODARD; Marie-Laure PAILLERE-MARTINOT, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems